Sequestering ErbB2 in endoplasmic reticulum by its autoinhibitor from translocation to cell surface: An autoinhibition mechanism of ErbB2 expression

Biochemical and Biophysical Research Communications

Volumn 342, Issue 1, 2006, Pages 19-27

  Hu, Pinliang ^a   Zhou, Tao ^b   Qian, Lu ^a   Wang, Jianing ^a   Shi, Ming ^a   Yu, Ming ^a   Yang, Yi ^b   Zhang, Xuemin ^b   Shen, Beifen ^a   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

Author keywords

Autoinhibitor; Autoregulation; Cell proliferation; Confocal microscopy; Ectodomain; Endoplasmic reticulum; erbB2; Growth factor receptor; Herstatin; Receptor internalization

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN; PROTEIN HERSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; GENE TRANSLOCATION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR CELL;

ANIMALS; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CRICETINAE; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR, ERBB-2;

ANIMALIA;

EID: 32644458214     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.115     Document Type: Article

References (36)

1. W.C. Dougall, X. Qian, N.C. Peterson, M.J. Miller, A. Samanta, and M.I. Greene The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies Oncogene 9 1994 2109 2123
2. N.E. Hynes, and D.F. Stern The biology of erbB-2/neu/HER-2 and its role in cancer Biochim. Biophys. Acta 1198 1994 165 184
3. M.A. Olayioye, R.M. Neve, H.A. Lane, and N.E. Hynes The ErbB signaling network: receptor heterodimerization in development and cancer EMBO J. 19 2000 3159 3167
4. R.J. Gilbertson, S.C. Clifford, W. MacMeekin, W. Meekin, C. Wright, R.H. Perry, P. Kelly, A.D. Pearson, and J. Lunec Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma Cancer Res. 58 1998 3932 3941
5. I. Alroy, and Y. Yarden The erbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions FEBS Lett. 410 1997 83 86
6. D. Graus-Porta, R.R. Beerli, M.J. Daly, and N.E. Hynes ErbB-2, the preferred heterodimerization parameter of all erbB receptors, is a mediator of lateral signaling EMBO J. 16 1997 1647 1655
7. C.H. Heldin, and A. Ostman Ligand-induced dimerization of growth factor receptors: variations on the theme Cytokine Growth Factor Rev. 7 1996 3 10
8. E. Tzahar, H. Waterman, X. Chen, G. Levkowitz, D. Karunagaran, S. Lavi, B.J. Ratzkin, and Y. Yarden A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor Mol. Cell. Biol. 16 1996 5276 5287
9. D.J. Riese 2nd, and D.F. Stern Specificity within the EGF family/ErbB receptor family signaling network Bioessays 20 1998 41 48
10. E. Tzahar, and Y. Yarden The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands Biochim. Biophys. Acta 1377 1998 M25 M37
11. D. Karunagaran, E. Tzahar, R.R. Beerli, X. Chen, D. Graus-Porta, B.J. Ratzkin, R. Seger, N.E. Hynes, and Y. Yarden ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer EMBO J. 15 1996 254 264
12. M.X. Sliwkowski, G. Schaefer, R.W. Akita, J.A. Lofgren, V.D. Fitzpatrick, A. Nuijens, B.M. Fendly, R.A. Cerione, R.L. Vandlen, and K.L. Carraway III Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin J. Biol. Chem. 269 1994 14661 14665
13. P.P. Di Fiore, J.H. Pierce, M.H. Kraus, O. Segatto, C.R. King, and S.A. Aaronson ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science 237 1987 178 182
14. R.M. Hudziak, J. Schlessinger, and A. Ullrich Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells Proc. Natl. Acad. Sci. USA 84 1987 7159 7163
15. F. Lonardo, E. Di Marco, C.R. King, J.H. Pierce, O. Segatto, S.A. Aaronson, and P.P. Di Fiore The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand New Biol. 2 1990 992 1003
16. Y. Kokai, J.N. Myers, T. Wada, V.I. Brown, C.M. LeVea, J.G. Davis, K. Dobashi, and M.I. Greene Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts Cell 58 1989 287 292
17. D.J. Riese 2nd, T.M. van Raaij, G.D. Plowman, G.C. Andrews, and D.F. Stern The cellular response to neuregulins is governed by complex interactions of the erbB receptor family Mol. Cell. Biol. 15 1995 5770 5776
18. R. Pinkas-Kramarski, M. Shelly, S. Glathe, B.J. Ratzkin, and Y. Yarden Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations J. Biol. Chem. 271 1996 19029 19032
19. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
20. H. Waterman, and Y. Yarden Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases FEBS Lett. 490 2001 142 152
21. L. Gilboa, R. Ben-Levy, Y. Yarden, and Y.I. Henis Roles for a cytoplasmic tyrosine and tyrosine kinase activity in the interactions of Neu receptors with coated pits J. Biol. Chem. 270 1995 7061 7067
22. J. Baulida, and G. Carpenter Heregulin degradation in the absence of rapid receptor-mediated internalization Exp. Cell Res. 232 1997 167 172
23. Z. Wang, L. Zhang, T.K. Yeung, and X. Chen Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation Mol. Biol. Cell 10 1999 1621 1636
24. J.K. Doherty, C. Bond, A. Jardim, J.P. Adelman, and G.M. Clinton The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor Proc. Natl. Acad. Sci. USA 96 1999 10869 10874
25. N.G. Azios, F.J. Romero, M.C. Denton, J.K. Doherty, and G.M. Clinton Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor Oncogene 20 2001 5199 5209
26. Q. Justman, and G.M. Clinton Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest J. Biol. Chem. 277 2002 20618 20624
27. J.N. Wang, J.N. Feng, M. Yu, M. Xu, M. Shi, T. Zhou, X.D. Yu, B.F. Shen, and N. Guo Structural analysis of the epitopes on erbB2 interacted with inhibitory or non-inhibitory monoclonal antibodies Mol. Immunol. 40 2004 963 969
28. K.L. Carraway III, and C. Sweeney Localization and modulation of ErbB receptor tyrosine kinases Curr. Opin. Cell Biol. 13 2001 125 130
29. L.N. Klapper, H. Waterman, and M. Sela Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2 Cancer Res. 60 2000 3384 3388
30. J. Baselga, and J. Albanell Mechanism of action of anti-HER2 monoclonal antibodies Ann. Oncol. 12 Suppl. 1 2001 S35 S41
31. M.X. Sliwkowski, J.A. Lofgren, G.D. Lewis, T.E. Hotaling, B.M. Fendly, and J.A. Fox Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin) Semin. Oncol. 26 Suppl. 12 1999 60 70
32. D. Graus-Porta, R.R. Beerli, and N.E. Hynes Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling Mol. Cell. Biol. 15 1995 1182 1191
33. R.R. Beerli, W. Wels, and N.E. Hynes Intracellular expression of single chain antibodies reverts ErbB-2 transformation J. Biol. Chem. 269 1994 23931 23936
34. W. Arafat, J. Gomez-Navarro, J. Xiang, G.P. Siegal, R.D. Alvarez, and D.T. Curiel Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target Cancer Gene Ther. 7 2000 1250 1256
35. P. Hu, J. Feng, T. Zhou, J. Wang, B. Jing, M. Yu, M. Hu, X. Zhang, B. Shen, and N. Guo In vivo identification of the interaction site of ErbB2 extracellular domain with its autoinhibitor J. Cell. Phys. 205 2005 335 343
36. F. Jhabvala-Romero, A. Evans, S. Guo, M. Denton, and G.M. Clinton Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2 oncogene 22 2003 8178 8186